首页> 美国卫生研究院文献>Blood Advances >Immune cytopenia post–cord transplant in Hurler syndrome is a forme fruste of graft rejection
【2h】

Immune cytopenia post–cord transplant in Hurler syndrome is a forme fruste of graft rejection

机译:Hurler综合征的免疫性血细胞减少症移植后移植物排斥反应

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Umbilical cord blood (UCB) is the preferred donor cell source for children with Hurler syndrome undergoing transplant, and its use has been associated with improved “engrafted survival” rates. However, as in other pediatric recipients of UCB transplants for nonmalignant disease, immune-mediated cytopenia (IMC) is a significant complication. This article describes 8 episodes of IMC in 36 patients with Hurler syndrome undergoing UCB transplant. The incidence of IMC was increased in those with a higher preconditioning absolute lymphocyte count and in those conditioned with fludarabine-containing regimens rather than cyclophosphamide, and it included red cell alloantibodies directed at cord blood group antigens that are novel to the recipient. In several cases, IMC was a precursor to immune-mediated complete graft rejection. We describe IMC as part of a spectrum of graft rejection by a residual competent host immune system and a forme fruste of complete graft rejection.
机译:脐带血(UCB)是接受移植的Hurler综合征患儿的首选供体细胞来源,其使用与提高“移植存活率”相关。但是,与其他非恶性疾病的UCB移植小儿接受者一样,免疫介导的血细胞减少症(IMC)是一个严重的并发症。本文介绍了36例接受UCB移植的Hurler综合征患者的IMC发作情况。在具有较高的预处理绝对淋巴细胞计数的患者中以及在使用氟达拉滨而非环磷酰胺治疗的患者中,IMC的发生率有所增加,并且它包括针对接受者新颖的脐带血型抗原的红细胞同种抗体。在某些情况下,IMC是免疫介导的完全移植排斥的先兆。我们将IMC描述为残余感受态宿主免疫系统和完全移植排斥反应的前档臂的移植排斥反应谱的一部分。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号